|
|
Arch Dis Child. 1990 September; 65(9): 942–945. | PMCID: PMC1792120 |
Prognosis of chronic granulomatous disease. A Finn, N Hadzić, G Morgan, S Strobel, and R J Levinsky Department of Immunology, Institute of Child Health, London. Abstract The records of 28 patients with chronic granulomatous disease born over a 32 year period were reviewed. The characteristics of the group, and the frequency with which various clinical and laboratory features had been recorded, was assessed. Nine patients were known to have died, in most cases of progressive suppurative infection. Actuarial analysis showed 50% survival through the third decade of life. The long term survival of patients developing symptoms after the end of the first year of life was significantly better than that of patients whose illness started in infancy. Our data confirm that the severity of chronic granulomatous disease is not uniform, and that the prognosis for long term survival is better than that suggested in earlier reports. Early onset may be a poor prognostic sign and invasive aspergillosis is a life threatening complication. In the absence of curative treatment, trials to assess the effectiveness of interferon gamma are necessary and early antenatal diagnosis should be offered to as many affected families as possible. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (672K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - BERENDES H, BRIDGES RA, GOOD RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–312. [PubMed]
- Holmes B, Quie PG, Windhorst DB, Good RA. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet. 1966 Jun 4;1(7449):1225–1228. [PubMed]
- Johnston RB, Jr, McMurry JS. Chronic familial granulomatosis. Report of five cases and review of the literature. Am J Dis Child. 1967 Oct;114(4):370–378. [PubMed]
- Johnston RB, Newman SL. Chronic granulomatous disease. Pediatr Clin North Am. 1977 May;24(2):365–376. [PubMed]
- Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989 Apr;114(4 Pt 1):555–560. [PubMed]
- Segal AW, Cross AR, Garcia RC, Borregaard N, Valerius NH, Soothill JF, Jones OT. Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983 Feb 3;308(5):245–251. [PubMed]
- Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, Parkos CA. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature. 327(6124):717–720. [PubMed]
- Teahan C, Rowe P, Parker P, Totty N, Segal AW. The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245. Nature. 327(6124):720–721. [PubMed]
- Dinauer MC, Orkin SH. Molecular genetics of chronic granulomatous disease. Immunodefic Rev. 1988;1(1):55–69. [PubMed]
- Okamura N, Curnutte JT, Roberts RL, Babior BM. Relationship of protein phosphorylation to the activation of the respiratory burst in human neutrophils. Defects in the phosphorylation of a group of closely related 48-kDa proteins in two forms of chronic granulomatous disease. J Biol Chem. 1988 May 15;263(14):6777–6782. [PubMed]
- Kamani N, August CS, Campbell DE, Hassan NF, Douglas SD. Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up. J Pediatr. 1988 Oct;113(4):697–700. [PubMed]
- Rappeport JM, Newburger PE, Goldblum RM, Goldman AS, Nathan DG, Parkman R. Allogeneic bone marrow transplantation for chronic granulomatous disease. J Pediatr. 1982 Dec;101(6):952–955. [PubMed]
- Gonzalez LA, Hill HR. Advantages and disadvantages of antimicrobial prophylaxis in chronic granulomatous disease of childhood. Pediatr Infect Dis J. 1988 Feb;7(2):83–85. [PubMed]
- Levinsky RJ, Harvey BA, Rodeck CH, Soothill JF. Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease. Clin Exp Immunol. 1983 Nov;54(2):595–598. [PubMed]
- Ezekowitz RA, Dinauer MC, Jaffe HS, Orkin SH, Newburger PE. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med. 1988 Jul 21;319(3):146–151. [PubMed]
- Sechler JM, Malech HL, White CJ, Gallin JI. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4874–4878. [PubMed]
- Battat L, Francke U. Nsi I RFLP at the X-linked chronic granulomatous disease locus (CYBB). Nucleic Acids Res. 1989 May 11;17(9):3619–3619. [PubMed]
- Schaller J. Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease. Ann Intern Med. 1972 May;76(5):747–750. [PubMed]
- Weening RS, Adriaansz LH, Weemaes CM, Lutter R, Roos D. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils. J Pediatr. 1985 Jul;107(1):102–104. [PubMed]
- Dilworth JA, Mandell GL. Adults with chronic granulomatous disease of "childhood". Am J Med. 1977 Aug;63(2):233–243. [PubMed]
- Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L, Buckley RH. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med. 1981 Jul;71(1):59–66. [PubMed]
|